tradingkey.logo

Teleflex Inc

TFX
查看详细走势图
108.420USD
+2.600+2.46%
收盘 02/06, 16:00美东报价延迟15分钟
4.79B总市值
亏损市盈率 TTM

Teleflex Inc

108.420
+2.600+2.46%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.46%

5天

+3.88%

1月

-14.31%

6月

-6.12%

今年开始到现在

-11.16%

1年

-36.63%

查看详细走势图

TradingKey Teleflex Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Teleflex Inc当前公司基本面数据相对健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名60/205位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价135.22。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Teleflex Inc评分

相关信息

行业排名
60 / 205
全市场排名
166 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Teleflex Inc亮点

亮点风险
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
高分红
公司属于高分红公司,最新股息支付率90.56%
稳定分红
公司5年内连续分红,最新股息支付率90.56%
估值低估
公司最新PE估值-15.11,处于3年历史低位
机构减仓
最新机构持股47.10M股,环比减少4.31%
ETHSX持仓
明星投资者ETHSX持仓,最新持仓市值343.00

分析师目标

根据 14 位分析师
持有
评级
135.221
目标均价
+27.57%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Teleflex Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Teleflex Inc简介

Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
公司代码TFX
公司Teleflex Inc
CEOKelly (Liam J)
网址https://www.teleflex.com/usa/en/#
KeyAI